Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies) - Image 1

£79.70

Springer Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Name: Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
Brand: Springer
Price: 79.3 GBP
Availability: InStock

Immunology

Price History & Forecast

Last 29 days • 29 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price

Price Analysis

Most common price: £79 (29 days, 100.0%)

Price range: £79 - £79

Price levels: 1 different prices over 29 days

Description

This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myelomaand Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3030132420
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Immunology
Domain: Amazon UK
Release Date: 21 November 2019
Listed Since: 14 February 2019

Barcode

No barcode data available

Springer Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Treatment of Multiple Myeloma and Related Disorders

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Myeloproliferative Neoplasms: Critical Concepts and Management (Hematologic Malignancies)

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

Myeloma Bone Disease (Current Clinical Oncology)

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Hematologic Malignancies: An Overview - Hematology Research

Acute Myeloid Leukemia (Hematologic Malignancies)

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Myeloproliferative Disorders: Symptoms, Risk Factors and Treatment Options (Recent Advances in Hematology Research)

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics